title: Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation Trial.
authors.affiliation: School of Public Health, Monash University, Melbourne, Victoria, Australia. sophia.zoungas@med.monash.edu.au
authors.forename: S
authors.initials: S
authors.lastname: Zoungas
authors.forename: M
authors.initials: M
authors.lastname: Lui
authors.forename: P G
authors.initials: PG
authors.lastname: Kerr
authors.forename: H J
authors.initials: HJ
authors.lastname: Teede
authors.forename: J J
authors.initials: JJ
authors.lastname: McNeil
authors.forename: B P
authors.initials: BP
authors.lastname: McGrath
authors.forename: K R
authors.initials: KR
authors.lastname: Polkinghorne
mesh_terms: D000328:Adult; D000368:Aged; D050197:Atherosclerosis / Q000188:drug therapy / Q000453:epidemiology*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology*; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000453:epidemiology*; D019587:Dietary Supplements; D004311:Double-Blind Method; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D005492:Folic Acid